Stock AVNT AVIENT CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Avient Corporation

Equities

AVNT

US05368V1061

Specialty Chemicals

Market Closed - Nyse
Other stock markets
 04:00:01 2024-04-26 pm EDT 		5-day change 1st Jan Change
43.22 USD +1.00% Intraday chart for Avient Corporation +1.65% +3.97%
Apr. 18 Oppenheimer Raises Avient Price Target to $49 From $45, Maintains Outperform Rating MT
Feb. 15 Deutsche Bank Adjusts Avient Price Target to $42 From $37, Maintains Hold Rating MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,830 3,685 5,119 3,070 3,790 3,944 - -
Enterprise Value (EV) 1 3,194 4,908 6,377 4,608 5,324 5,433 5,219 5,025
P/E ratio 4.85 x 27.8 x 22.3 x 4.42 x 50.1 x 27.2 x 23.3 x -
Yield 2.14% 2.04% 1.56% 2.84% 2.41% 2.39% 2.55% 2.64%
Capitalization / Revenue 0.99 x 1.14 x 1.06 x 0.9 x 1.21 x 1.22 x 1.16 x 1.09 x
EV / Revenue 1.12 x 1.51 x 1.32 x 1.36 x 1.69 x 1.68 x 1.53 x 1.39 x
EV / EBITDA 10.1 x 13.1 x 11 x 7.79 x 10.6 x 10.3 x 9.04 x 7.8 x
EV / FCF 14.5 x 31.1 x 47.9 x 15.7 x 64.8 x 35.6 x 25.4 x -
FCF Yield 6.89% 3.22% 2.09% 6.36% 1.54% 2.81% 3.94% -
Price to Book 2.72 x 2.17 x 2.89 x 1.33 x - 1.65 x 1.56 x 1.44 x
Nbr of stocks (in thousands) 76,915 91,476 91,491 90,944 91,161 91,255 - -
Reference price 2 36.79 40.28 55.95 33.76 41.57 43.22 43.22 43.22
Announcement Date 1/28/20 2/9/21 2/8/22 2/15/23 2/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2,863 3,242 4,819 3,397 3,143 3,228 3,403 3,612
EBITDA 1 316 374.8 581.2 591.7 501.8 526.7 577.6 644.1
EBIT 1 228.5 263 429 352 312.8 334.6 388.6 454.8
Operating Margin 7.98% 8.11% 8.9% 10.36% 9.95% 10.36% 11.42% 12.59%
Earnings before Tax (EBT) 1 109.4 139 304.6 63.8 87.3 192.7 225.7 -
Net income 1 588.6 131.6 230.8 703.1 75.7 146.6 170.9 -
Net margin 20.56% 4.06% 4.79% 20.7% 2.41% 4.54% 5.02% -
EPS 2 7.580 1.450 2.510 7.630 0.8300 1.590 1.853 -
Free Cash Flow 1 220 157.9 133.2 292.9 82.2 152.7 205.6 -
FCF margin 7.69% 4.87% 2.76% 8.62% 2.62% 4.73% 6.04% -
FCF Conversion (EBITDA) 69.62% 42.13% 22.92% 49.5% 16.38% 28.99% 35.6% -
FCF Conversion (Net income) 37.38% 119.98% 57.71% 41.66% 108.59% 104.11% 120.3% -
Dividend per Share 2 0.7880 0.8200 0.8750 0.9600 1.000 1.033 1.101 1.140
Announcement Date 1/28/20 2/9/21 2/8/22 2/15/23 2/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 1,220 1,202 1,294 1,302 823.3 790.4 845.7 824.4 753.7 719 814.2 826.7 810.1 769.5 849.2
EBITDA 1 135.9 125.8 171.4 169.7 119.3 190.8 133.8 131.3 122.7 113.9 136.2 138.4 130 120.3 147.8
EBIT 1 98.7 85.2 136.4 133.8 80.8 60.3 84.2 84.1 75.3 69.2 88.75 91.7 83.19 72.92 -
Operating Margin 8.09% 7.09% 10.54% 10.27% 9.81% 7.63% 9.96% 10.2% 9.99% 9.62% 10.9% 11.09% 10.27% 9.48% -
Earnings before Tax (EBT) 1 61.1 51.1 111.1 114.7 -29 -77.4 29 32.7 5 20.6 49.65 52.2 42.4 32.25 55.6
Net income 1 52.9 29.8 84.2 84.7 -10.3 544.5 19.9 22.1 5.1 28.6 38.45 38.25 32.8 24.85 42.3
Net margin 4.34% 2.48% 6.51% 6.5% -1.25% 68.89% 2.35% 2.68% 0.68% 3.98% 4.72% 4.63% 4.05% 3.23% 4.98%
EPS 2 0.5700 0.3200 0.9100 0.9200 -0.1100 5.980 0.2200 0.2400 0.0600 0.3100 0.4150 0.4200 0.3550 0.2700 0.4600
Dividend per Share 2 0.2125 0.2375 0.2375 0.2375 0.2375 0.2475 0.2475 0.2475 0.2475 0.2575 0.2590 0.2590 0.2590 0.2590 -
Announcement Date 10/28/21 2/8/22 4/20/22 7/26/22 11/2/22 2/15/23 5/3/23 7/27/23 11/2/23 2/14/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 365 1,223 1,258 1,538 1,534 1,489 1,275 1,081
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.154 x 3.263 x 2.164 x 2.599 x 3.057 x 2.827 x 2.208 x 1.679 x
Free Cash Flow 1 220 158 133 293 82.2 153 206 -
ROE (net income / shareholders' equity) - 11.5% 13.3% 12.1% 9.3% 8.46% 9.6% 9.86%
ROA (Net income/ Total Assets) - 3.85% 4.68% 4.48% 3.6% 3.8% 4.1% -
Assets 1 - 3,418 4,934 15,710 2,103 3,859 4,168 -
Book Value Per Share 2 13.50 18.60 19.40 25.30 - 26.20 27.70 30.00
Cash Flow per Share 2 - - - 4.320 2.200 3.920 4.410 4.890
Capex 1 81.7 63.7 101 106 119 140 135 140
Capex / Sales 2.85% 1.96% 2.09% 3.11% 3.8% 4.33% 3.97% 3.88%
Announcement Date 1/28/20 2/9/21 2/8/22 2/15/23 2/14/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Avient Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
43.22 USD
Average target price
46.71 USD
Spread / Average Target
+8.08%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

1st Jan change Capi.
AVIENT CORPORATION Stock Avient Corporation
+3.97% 3.94B
ECOLAB INC. Stock Ecolab Inc.
+11.47% 63.22B
SIKA AG Stock Sika AG
-3.47% 46.34B
GIVAUDAN SA Stock Givaudan SA
+13.72% 39.97B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+17.83% 25.46B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+7.27% 18.68B
CELANESE CORPORATION Stock Celanese Corporation
-0.57% 17.24B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.73% 15.81B
SYMRISE AG Stock Symrise AG
+0.22% 14.9B
ALBEMARLE CORPORATION Stock Albemarle Corporation
-19.10% 13.74B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. AVNT Stock
  4. Financials Avient Corporation